Home › Funds › Ninety One North America, Inc. › EW
Ninety One North America, Inc. position in EW
EDWARDS LIFESCIENCES CORP · Health Care
Ninety One North America, Inc. reported holding 582,170 shares of EW (EDWARDS LIFESCIENCES CORP) in its Q3 2026 13F filing — a position valued at US$50.3M, representing 2.36% of its reported portfolio and ranking #11 among its reported holdings. Ninety One North America, Inc. has disclosed EW holdings in 9 of the last 9 reported quarters, going back to Q3 2024.
Last updated: 2026-10-15 · Source: SEC EDGAR Form 13F-HR
How Ninety One North America, Inc.'s EW position evolved
Ninety One North America, Inc. first disclosed a stake in EW in Q3 2024 at 369,018 shares (US$24.4M). The position peaked in Q2 2026 at 616,498 shares, worth US$55.8M. Across 9 filings, Ninety One North America, Inc. increased the stake 4 time(s), trimmed it 4 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 582,170 shares valued at US$50.3M — a reduction of -34,328 shares quarter over quarter.. Notable position changes include a 47% increase in Q2 2025 (shares were roughly flat over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2024 | 369.02K | $24.35M | New |
| Q4 2024 | 354.00K | $26.21M | Reduce |
| Q1 2025 | 327.71K | $23.75M | Reduce |
| Q2 2025 | 480.38K | $37.57M | Add |
| Q3 2025 | 551.40K | $42.88M | Add |
| Q4 2025 | 567.94K | $48.42M | Add |
| Q1 2026 | 637.33K | $51.04M | Add |
| Q2 2026 | 616.50K | $55.77M | Reduce |
| Q3 2026 | 582.17K | $50.25M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About EW and 13F data
EW (EDWARDS LIFESCIENCES CORP) is a Health Care company. 34 other funds we track also report a position in EW — the largest reported positions include DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt (US$1.18B), Ninety One UK Ltd (US$1.03B), Aristotle Capital Management, LLC (US$783.9M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding EW
- DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt 13.00M sh · $1.18B · Q2 2026
- Ninety One UK Ltd 11.94M sh · $1.03B · Q3 2026
- Aristotle Capital Management, LLC 8.67M sh · $783.91M · Q2 2026
- BROWN ADVISORY INC 7.37M sh · $666.33M · Q2 2026
- Artisan Partners Limited Partnership 6.63M sh · $599.36M · Q2 2026
- WELLCOME TRUST LTD (THE) as trustee of the WELLCOME TRUST 4.80M sh · $434.21M · Q2 2026
More on Ninety One North America, Inc.
FAQ
How long has Ninety One North America, Inc. held EW?
Ninety One North America, Inc. has disclosed EW holdings in 9 of the last 9 reported quarters, going back to Q3 2024.
What is Ninety One North America, Inc.'s current position in EW?
As of Q3 2026, Ninety One North America, Inc. holds 582.17K shares of EW (EDWARDS LIFESCIENCES CORP), valued at $50.25M, representing 2.36% of its reported portfolio and ranking #11.
Has Ninety One North America, Inc. been buying or selling EW?
In the latest 13F filing (Q3 2026), Ninety One North America, Inc. reduced its position in EW. The position peaked in Q2 2026 at 616.50K shares.
Which other funds hold EW?
Other major institutional holders of EW include DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt, Ninety One UK Ltd, Aristotle Capital Management, LLC, among 34 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.